Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference
06:00am, Tuesday, 28'th Feb 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Michael Benkowitz, President and
United Therapeutics (UTHR) Q4 Earnings & Sales Miss Estimates
01:33pm, Thursday, 23'rd Feb 2023
United Therapeutics' (UTHR) fourth-quarter earnings and sales miss estimates. Tyvaso sales continue to drive the company's top line.
United Therapeutics Corporation (UTHR) Q4 2022 Earnings Call Transcript
03:19pm, Wednesday, 22'nd Feb 2023
United Therapeutics Corporation (NASDAQ:UTHR ) Q4 2022 Earnings Conference Call February 22, 2023 9:00 AM ET Company Participants Dewey Steadman - Head-Investor Relations Martine Rothblatt - Chairpers
United Therapeutics (UTHR) Q4 Earnings and Revenues Miss Estimates
08:17am, Wednesday, 22'nd Feb 2023
United Therapeutics (UTHR) delivered earnings and revenue surprises of -35.19% and 0.19%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy United Therapeutics (UTHR) Ahead of Earnings?
12:48pm, Tuesday, 21'st Feb 2023
United Therapeutics (UTHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its fourth quarter and full year 2022 financial r
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Monday, 13'th Feb 2023
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
United Therapeutics: Incremental Profitability Gains Justify Premium
05:32pm, Wednesday, 08'th Feb 2023
The market has swiftly priced in United Therapeutics Corporation's patent dispute. The company exhibits strong profitability momentum, with growth coming in at a low cost to earnings.
UTHR vs. ZTS: Which Stock Is the Better Value Option?
12:47pm, Friday, 27'th Jan 2023
UTHR vs. ZTS: Which Stock Is the Better Value Option?
After Plunging -5.18% in 4 Weeks, Here's Why the Trend Might Reverse for United Therapeutics (UTHR)
11:18am, Thursday, 19'th Jan 2023
United Therapeutics (UTHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings
UTHR or ESALY: Which Is the Better Value Stock Right Now?
12:48pm, Monday, 09'th Jan 2023
UTHR vs. ESALY: Which Stock Is the Better Value Option?
3 Biotech Companies to Watch in 2023
06:50pm, Friday, 06'th Jan 2023
Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their rel
New Strong Buy Stocks for January 4th
09:02am, Wednesday, 04'th Jan 2023
STAA, CASY, THRM, MP and UTHR have been added to the Zacks Rank #1 (Strong Buy) List on January 4 , 2023.
United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
06:00am, Monday, 02'nd Jan 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer
Red-Hot Fund Managers Expect Rocky Start To 2023
12:00pm, Monday, 19'th Dec 2022
Want to know how to invest in 2023? Red-hot fund manager Dale Harvey says individual investors should fasten their seat belts.
